China set to lead recovery of East Asian and Pacific economies -World Bank

2 minute read
Register now for FREE unlimited access to

March 26 (Reuters) - China is expected to lead the recovery of East Asian and Pacific economies this year, but many nations will record sub-par growth as they struggle to emerge from the coronavirus pandemic, according to new World Bank forecasts released on Friday.

Excluding China, by far the region’s biggest economy, growth will only be 4.4% in East Asia and the Pacific, an improvement on a 3.7% contraction the year before but still below the long-term average.

Vietnam is the other outstanding economic performer with an expected growth rate of 6.6%, up from 2.9%. China and Vietnam were among the relatively few countries that were only lightly hit by the pandemic and did not fall into recession in 2020.

Register now for FREE unlimited access to

"Like Hydra, the many-headed monster of Greek myth, COVID-19 is proving hard to suppress even a year after the first case was confirmed in Wuhan," the World Bank said.

It noted that economic growth for individual nation-states "will depend on containing the novel coronavirus; their ability to take advantage of a revival of international trade; and the capacity of governments to provide fiscal and monetary support".

"Global economic recovery, supported in part by the significant U.S. stimulus, will revive trade in goods and could provide an external boost to growth of as much as 1 percentage point on average," the report said. "But global tourism is expected to remain below pre-pandemic levels till 2023 and delay economic recovery in tourism-dependent economies."

The World Bank said "successful vaccination campaigns and early control of the pandemic, together with significant policy reform and the diffusion of new technologies" could lead to better-the-expected growth.

Slow suppression of COVID-19, however, could lead to worse-than-anticipated economic activity, increasing the risk of the emergence of new variants that could be more infectious, lethal and resistant to existing vaccines.

Register now for FREE unlimited access to
Reporting by Tom Allard

Our Standards: The Thomson Reuters Trust Principles.